Press release
Global Neuropathic Pain Treatment Market Trends 2020 | Segmentation, Outlook, Industry Report to 2026
The global neuropathic pain treatment market is estimated to grow at a CAGR of nearly 5.8% during the forecast period. The demand for neurostimulation therapy for neuropathic pain management is expected to emerge owing to its significant potential in pain relief by interrupting the pain signals traveling between the brain and the spinal cord. Rising spinal cord injuries and diabetic neuropathy complications have led the demand for more potential and reliable pain management treatment, which in turn, will likely offer scope for neurostimulation therapy. As of 2019, the estimated number of individuals suffering from spinal cord injury in the US is nearly 291,000. Nearly 78% of new incidences were reported among males.To Request a Sample of our Report on Global Neuropathic Pain Treatment Market: https://www.omrglobal.com/request-sample/neuropathic-pain-treatment-market
Neuropathic pain is the most common in patients suffering from spinal cord injury and usually difficult to treat. Spinal cord stimulation is an emerging technique that can be preferably used in interdisciplinary pain treatment. The main indications to use spinal cord stimulation include neuropathic pain conditions such as peripheral nerve injuries or complex regional pain syndrome (CRPS) or as well as mixed neuropathic conditions such as failed back surgery syndrome (FBSS). In spinal cord stimulation therapy, the electric pulses alter and mask the pain signals before they reach the brain.
It is a small device, like a pacemaker that delivers electrical pulses to the spinal cord and thereby supports people to effectively manage their chronic pain and decrease their use of opioid medications. It is considered as a safe, minimally invasive, and reversible treatment. However, further research is required to find out more evidence of the potential effects of spinal cord stimulation in neuropathy pain management, which may support to leverage the adoption of this therapy for the condition. The major companies in the field of neurostimulation include Abbott Laboratories, Boston Scientific Corp., and Medtronic plc.
These companies are focusing on developing neurostimulation devices to potentially manage neuropathic pain. For instance, in January 2017, Abbott Laboratories declared the introduction of the new Proclaim DRG neurostimulation system, which is developed to deliver dorsal root ganglion (DRG) stimulation to people with chronic neuropathic pain. The Proclaim DRG neurostimulation system delivers a more intuitive therapy experience to the patients coupled with the Proclaim platform's Bluetooth wireless technology and iOS software. The Proclaim DRG neurostimulation system targets nerves within the DRG and thus, it has been clinically demonstrated to offer better pain relief than conventional spinal cord stimulation therapy as it directly targets the area of the body where pain occurs to improve quality of life.
The approval of Proclaim DRG neurostimulation system is offering access to this platform for the patients suffering from chronic neuropathic pain. The system features magnetic resonance (MR)-conditional recharge-free system that delivers better programming, increased battery capacity, and upgradeability. It also uses an iPod touch mobile digital device patient controller that provides wireless communication through Bluetooth wireless technology. Such kinds of innovations in neurostimulation devices will increase the reliability and efficacy of these devices for neuropathic pain treatment, which in turn, is expected to drive the global neuropathic pain treatment market.
(Get 15% Discount on Buying this Report)
A full Report of Global Neuropathic Pain Treatment Market is Available at: https://www.omrglobal.com/industry-reports/neuropathic-pain-treatment-market
Global Neuropathic Pain Treatment Market- Segmentation
By Indication
• Spinal Stenosis
• Diabetic Neuropathy
• Chemotherapy-Induced Peripheral Neuropathy
• Others
By Treatment
• Tricyclic Antidepressants
• Anticonvulsants
• Opioids
• Creams and Patches
• Steroids
• Others (Neurostimulation and Local Anesthesia)
Global Neuropathic Pain Treatment Market– Segment by Region
North America
• US
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East and Africa
Company Profiles
• Abbott Laboratories
• Acorda Therapeutics, Inc.
• Assertio Therapeutics, Inc.
• Astellas Pharma Inc.
• AstraZeneca plc
• Biogen Inc.
• BioIntervene, Inc.
• Boston Scientific Corp.
• Cipla Ltd.
• Dr. Reddy’s Laboratories Ltd.
• Eli Lilly and Co.
• GlaxoSmithKline plc
• Glenmark Pharmaceuticals Ltd.
• Grünenthal GmbH
• Johnson & Johnson Services, Inc.
• Lexicon Pharmaceuticals, Inc.
• Lupin Ltd.
• Medtronic plc
• Pfizer Inc.
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neuropathic-pain-treatment-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Neuropathic Pain Treatment Market Trends 2020 | Segmentation, Outlook, Industry Report to 2026 here
News-ID: 2247075 • Views: …
More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033.
Road Marking Paint Market Overview
The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new…

Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period.
Outboard Boat Market Overview
The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including…

Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033.
Mobile Ticketing Market Overview
The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,…

Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033.
Metal Alloy Market Overview
The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in…
More Releases for Neuropathic
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
Global Neuropathic Pain Market Research Report Forecast to 2023
Neuropathic Pain Market 2020 comprises a detailed survey of the Neuropathic Pain Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025.
Global "Neuropathic Pain" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Neuropathic Pain market in terms of thriving companies, business methods, product values and pricing, revenue,…